Search
S-Hydroxycysteine
go.drugbank.com/drugs/DB01915ExperimentalThese are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. … S-hydroxycysteine is a solid. This compound belongs to the alpha amino acids and derivatives.
Anistreplase
go.drugbank.com/drugs/DB00029ApprovedWithdrawnA p-anisoyl group is chemically conjugated to a complex of bacterial-derived streptokinase and human Plasma-derived Lys-plasminogen proteins. … Eminase is a lyophilized (freeze-dried) formulation of anistreplase, the p-anisoyl derivative of the primary Lys-plasminogen-streptokinase activator complex (a complex of Lys-plasminogen and streptokinase
Pentamorphone
go.drugbank.com/drugs/DB20947ExperimentalPentamorphone is a small molecule drug. Pentamorphone has a monoisotopic molecular weight of 368.21 Da.
Categories: Heterocyclic Compounds with 4 or More RingsSynonyms: 14b-n-pentylaminomorphinoneNV-07a
go.drugbank.com/drugs/DB05845ExperimentalNV-07a is topical skin repair compound protecting skin from sun-induced immunosuppression and UV-induced damage.
Orgotein
go.drugbank.com/drugs/DB11444ExperimentalVet approvedSuperoxide dismutase (SOD) is an enzyme that alternately catalyzes the dismutation of the superoxide radical into either the less damaging hydrogen peroxide or molecular oxygen. … A notable exception is Lactobacillus plantarum.
Endralazine
go.drugbank.com/drugs/DB13435ExperimentalCategories: Arteriolar Smooth Muscle, Agents Acting OnEmetonium iodide
go.drugbank.com/drugs/DB13769ExperimentalCategories: Drugs for Functional Gastrointestinal DisordersEpicriptine
go.drugbank.com/drugs/DB11275ApprovedEpicriptine is also known as beta-dihydroergocryptine presents a molecular formula of 9,10 alpha-dihydro-13'-epi-b-ergocryptine. … Epicriptine differs from the alpha form on the position of one methyl group.[T195] To know more about the mixture please visit [DB01049]
Emepronium
go.drugbank.com/drugs/DB13505ExperimentalCategories: Drugs for Urinary Frequency and Incontinence, Drugs for Functional Gastrointestinal DisordersSirna-027
go.drugbank.com/drugs/DB05896InvestigationalSirna-027 is a chemically modified short interfering RNA(siRNA) targeting Vascular Endothelial Growth Factor Receptor-1(VEGFR-1). … VEGFR-1 is a key component of the clinically validated vascular endothelial growth factor (VEGF) pathway. Sirna-027 is developed by Sirna Therapeutics and is under the phase I of clinical trails.